Acorda Therapeutics, Inc. Operating Lease, Payments
Acorda Therapeutics, Inc. reported Operating Lease, Payments of $397.00 thousand for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-14.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2024-05-14
- Acorda Therapeutics, Inc. operating lease, payments for the quarter ending 2024-03-31 was $397.00K, a 2.85% increase year-over-year.
- Acorda Therapeutics, Inc. operating lease, payments for the quarter ending 2023-12-31 was $1.16M, a 85.32% decline year-over-year.
- Acorda Therapeutics, Inc. operating lease, payments for the quarter ending 2023-09-30 was $0.00.
- Acorda Therapeutics, Inc. operating lease, payments for the quarter ending 2023-06-30 was $0.00, a 100.00% decline year-over-year.
- Acorda Therapeutics, Inc. operating lease, payments for fiscal 2023 was $1.54M, a 81.14% decline from fiscal 2022.
- Acorda Therapeutics, Inc. operating lease, payments for fiscal 2022 was $8.19M, a 33.01% increase from fiscal 2021.
- Acorda Therapeutics, Inc. operating lease, payments for fiscal 2021 was $6.16M, a 20.74% decline from fiscal 2020.
- Acorda Therapeutics, Inc. operating lease, payments for fiscal 2020 was $7.77M, a 3.49% increase from fiscal 2019.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month |
|---|---|---|---|---|
| 2024-03-31 | $397.00K 10-Q · filed 2024-05-14 | $1.56M derived: sum of 2 quarters · filed 2024-05-14 | $1.56M derived: sum of 3 quarters · filed 2024-05-14 | $1.56M derived: sum of 4 quarters · filed 2024-05-14 |
| 2023-12-31 | $1.16M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $1.16M derived: sum of 2 quarters · filed 2024-04-01 | $1.16M derived: sum of 3 quarters · filed 2024-04-01 | $1.54M 10-K · filed 2024-04-01 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $0.00 derived: sum of 2 quarters · filed 2023-11-14 | $386.00K 10-Q · filed 2023-11-14 | $8.28M derived: sum of 4 quarters · filed 2024-05-14 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $386.00K 10-Q · filed 2023-08-09 | $8.28M derived: sum of 3 quarters · filed 2024-05-14 | $2.54M derived: sum of 4 quarters · filed 2024-05-14 |
| 2023-03-31 | $386.00K 10-Q · filed 2024-05-14 | $8.28M derived: sum of 2 quarters · filed 2024-05-14 | $2.54M derived: sum of 3 quarters · filed 2024-05-14 | $7.01M derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $7.90M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $2.15M derived: sum of 2 quarters · filed 2024-04-01 | $6.63M derived: sum of 3 quarters · filed 2024-04-01 | $8.19M 10-K · filed 2024-04-01 |
| 2022-09-30 | -$5.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$1.27M derived: sum of 2 quarters · filed 2023-11-14 | $295.00K 10-Q · filed 2023-11-14 | $1.85M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $4.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $6.04M 10-Q · filed 2023-08-09 | $7.59M derived: sum of 3 quarters · filed 2023-08-09 | $9.15M derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | $1.56M 10-Q · filed 2023-05-11 | $3.12M derived: sum of 2 quarters · filed 2023-05-11 | $4.67M derived: sum of 3 quarters · filed 2023-05-11 | $6.20M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $1.55M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $3.11M derived: sum of 2 quarters · filed 2023-03-15 | $4.64M derived: sum of 3 quarters · filed 2023-03-15 | $6.16M 10-K · filed 2023-03-15 |
| 2021-09-30 | $1.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $3.08M derived: sum of 2 quarters · filed 2022-11-14 | $4.61M 10-Q · filed 2022-11-14 | $6.56M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $1.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $3.05M 10-Q · filed 2022-08-09 | $5.00M derived: sum of 3 quarters · filed 2022-08-09 | $6.95M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | $1.52M 10-Q · filed 2022-05-13 | $3.47M derived: sum of 2 quarters · filed 2022-05-13 | $5.42M derived: sum of 3 quarters · filed 2022-05-13 | $7.37M derived: sum of 4 quarters · filed 2022-05-13 |
| 2020-12-31 | $1.95M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-18 | $3.90M derived: sum of 2 quarters · filed 2022-03-18 | $5.85M derived: sum of 3 quarters · filed 2022-03-18 | $7.77M 10-K · filed 2022-03-18 |
| 2020-09-30 | $1.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $3.90M derived: sum of 2 quarters · filed 2021-11-12 | $5.82M 10-Q · filed 2021-11-12 | $7.72M derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-06-30 | $1.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $3.87M 10-Q · filed 2021-08-12 | $5.77M derived: sum of 3 quarters · filed 2021-08-12 | $7.67M derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | $1.92M 10-Q · filed 2021-05-12 | $3.82M derived: sum of 2 quarters · filed 2021-05-12 | $5.72M derived: sum of 3 quarters · filed 2021-05-12 | $7.59M derived: sum of 4 quarters · filed 2021-05-12 |
| 2019-12-31 | $1.90M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $3.80M derived: sum of 2 quarters · filed 2021-03-16 | $5.67M derived: sum of 3 quarters · filed 2021-03-16 | $7.51M 10-K · filed 2021-03-16 |
| 2019-09-30 | $1.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $3.77M derived: sum of 2 quarters · filed 2020-11-06 | $5.61M 10-Q · filed 2020-11-06 | |
| 2019-06-30 | $1.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $3.71M 10-Q · filed 2020-08-07 | ||
| 2019-03-31 | $1.83M 10-Q · filed 2020-05-08 |